Anhydride propionique, min 98,5 %, pour la synthèse, 100 ml, emballage en verre

3-Amino-1-phenylpropan-1-ol oxalate, 97.0%, 250mg

2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 95.0%, 1g

5-Bromothiazole-2-carbonitrile, 95.0%, 500mg

4-[(6-Diethylamino-pyrimidin-4-yl)-methyl-amino]-piperidine-1-carboxylic acid tert-butyl ester, 95.0%, 250mg

2-(4-Isopropoxy-2-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 10g

1-(PIPERIDIN-4-YLMETHYL)-3-(THIAZOL-2-YL)UREA 2HCL, 95.0%, 250mg

3-Chloro-4-(3-pyridin-2-yl-ureido)benzenesulfonylchloride hydrogen sulfate, 250mg

2-Nitro-5-(trifluoromethyl)phenol, 95.0%, 5g

tert-Butyl 5-oxo-7-azabicyclo[2.2.1]hept-2-ene-7-carboxylate, 98%, 1g

8-tert-butyl-4-(3-fluorobenzoyl)-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

5-BROMO-6-CHLORO-4(3H)-PYRIMIDINONE, 95%, 5g

Acide 3-méthoxysalicylique, min 97 %, pour la synthèse, 25 g, emballage en verre